Longwood Healthcare Leaders Fall Webconference
September 21 - 22, 2022
The Longwood Healthcare Leaders Fall webconference brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients.
Registered participants are invited to join a cocktail party
with Maura Healey, leading MA gubernatorial candidate
at The Country Club in Brookline, MA,
site of the 2022 US Open Golf Championship.
Wednesday, September 21, 2022
7:00 am ET
LONGWOOD FUND INTRODUCTION
David Steinberg, General Partner, Longwood Fund
7:30 am ET
MOVING BEYOND NEWCO
Michael Ackermann, Chair, Tarsus
Laurence Blumberg, former CEO, Arch Oncology
Hiro Kimura, Investment Director, Astellas Pharma
John McCabe, CFO & COO, DEM Bio
Moderator: Luba Greenwood, CEO, Kojin Therapeutics
8:00 am ET
RNAi REVOLUTION: THE ALNYLAM STORY
John Maraganore, former CEO, Alnylam
Barry Greene, CEO, Sage; former President, Alnylam
Moderator: Christoph Westphal, founding CEO, Alnylam; General Partner, Longwood Fund
8:20 am ET
BIG BIOPHARMA PIPELINE SOURCING
Rich Colvin, CMO, Bluebird Bio
Kathy Fernando, Head, mRNA Scientific Strategy, Head, WRDM Operations, Pfizer
Heather Huet, Head, Oncology Strategy & Operations, Takeda
Gilmore O'Neill, CEO, Editas
Brandon Turunen, Head, US Chemical Biology, GlaxoSmithKline
Moderator: John Westwood, Partner & Global Leader, Life Sciences, Oliver Wyman
8:50 am ET
APPROVALS: INSIGHTS, OUTLOOK, AND COMMITMENT TO PATIENTS
Kabir Nath, CEO, Compass Pathways
Andrew Obenshain, CEO, bluebird bio
Ryan Richardson, Chief Strategy Officer, BioNTech
Moderator: Jeremy Levin, CEO, Ovid Therapeutics
9:20 am ET
EARLY PREPARATION FOR PARTNERING
Jennifer Cayer, CBO, Pulmocide
Jason Coloma, CEO, Maze Therapeutics
Matt Gline, CEO, Roivant Sciences
Kate Haviland, CEO, Blueprint Medicines
Moderator: Robert LaCaze, CEO, Mnemo Therapeutics
9:50 am ET
CREATING A WORLD WITHOUT DISEASE
Anne Klibanski, President & CEO, Mass General Brigham
Peter Lebowitz, SVP & Head, Global Oncology, Janssen
Richard Paulson, CEO, Karyopharm
Cindy Perettie, Head, Molecular Labs, Roche Diagnostics
Jan Pinkas, CSO, Pyxis Oncology
Moderator: Chen Schor, President & CEO, Adicet Bio
10:20 am ET
REGULATORY & INDUSTRY ROUNDTABLE
Mikael Dolsten, CSO & President, WW Research, Development and Medical, Pfizer
Peter Marks, Director, CBER, FDA
Christoph Westphal, General Partner, Longwood Fund
10:40 am ET
THE NEXT WAVE OF TARGETED THERAPIES
Stewart Campbell, CEO, Axial Therapeutics
Judy Chou, CEO, AltruBio
Sandra Glucksmann, CEO, Cedilla Therapeutics
Rick Morgan, CSO, Be Bio
Kathy Seidl, Head, Oncology Drug Discovery, Takeda
Moderator: Armon Sharei, CEO, SQZ Biotech
11:15 am ET
R&D COLLABORATION
Hans Clevers, Head, pRED, Roche
Elliot Ehrich, President, Skyhawk Therapeutics
Jak Knowles, CEO, Affini-T Therapeutics
Greg LaRosa, Head, Scientific Research Rare Disease, Pfizer
Moderator: Beth Shafer, Head, R&D BD, GI, NS, DDS & Externalizations, Takeda
11:50 am ET
SCIENTIFIC INNOVATION: LAUNCHING COMPANIES FROM ACADEMIA
Sangeeta Bhatia, Director, Marble Center for Cancer Nanomedicine, Koch Institute at MIT
Christina Coughlin, CEO, CytoImmune Therapeutics
David Donabedian, Co-Founder, Interim President & CEO, DEM Bio
Mark Leuchtenberger, CEO, SpyBiotech
Kai Wucherpfennig, Chair, Cancer Immunology & Virology, Dana-Farber Cancer Institute
Moderator: Joel Marcus, Executive Chair & Founder, Alexandria Real Estate Equities
12:25 pm ET
SOURCING AND IDENTIFYING NOVEL TECHNOLOGY
Juliette Han, COO, Cambrian Biopharma
Nik Kojic, CEO, Oryon Cell Therapies
Anand Parikh, CEO, Faeth Therapeutics
Ryan Schoenfeld, CEO, The Mark Foundation for Cancer Research
Tom Wilton, CBO, Carisma Therapeutics
Moderator: Bruce Sunstein, Partner, Sunstein LLP
1:00 pm ET
EXPEDITING RESEARCH FOR TREATMENTS AND CURES
Raj Devraj, CEO, Rectify Pharmaceuticals
Rachelle Jacques, CEO, Akari
Saul Kato, CEO, Herophilus
Josh Lehrer, CEO, Graphite Bio
Shiladitya Sengupta, Associate Professor, Medicine, Harvard Medical School
Moderator: Gaurav Shah, CEO, Rocket Pharmaceuticals
1:30 pm ET
FIRESIDE CHAT: PATIENT ACCESS
Julie Gerberding, CEO, Foundation for the NIH; former director, CDC
David Loew, CEO, Ipsen
Moderator: Maria Whitman, Managing Principal, Global Pharmaceutical & Biotech Industry, ZS Associates
1:50 pm ET
DESIGNING THE DEAL
Sandy Mong, SVP, BD & Operations, Curie Therapeutics
Steve Perrin, President & CSO, Eledon Pharmaceuticals
Bob Silverman, CBO, Rejuveron
Moderator: Stuart Mackey, Global Head, BD, Daiichi Sankyo
2:20 pm ET
DRUG DISCOVERY SCIENCES
Marcelo Bigal, CEO, Ventus Therapeutics
Jane Grogan, CSO, Graphite Bio
Stefen Laukien, CEO, Retroviral Therapeutics
Marie-Claire Peakman, Executive Director, Emerging Science & Innovation WWRD, Pfizer Ventures
David Southwell, CEO, TScan Therapeutics
Moderator: Iris Grossman, CSO, Eleven Therapeutics
2:50 pm ET
ACCELERATING THE PATH TO PATIENT CARE
Jennifer Buell, CEO, MiNK
Jamie Dowd, North America Health Lead, Weber Shandwick
John Renger, CSO, Cerevel
Kevin Tabb, CEO, Beth Israel Lahey Health
Moderator: David Weinreich, EVP, Head, Global Clinical Development, Regeneron
3:20 pm ET
FIRESIDE CHAT
John Lepore,SVP, Head of Research, GlaxoSmithKline
David Reese, EVP, R&D, Amgen
Moderator: Aaron Mitchell, Principal, ZS Associates
3:40 pm ET
EXTERNAL INNOVATION
Diana Gallagher, Head, External Innovation, Biogen
Jim List, Global Therapeutic Area Head, Cardiovascular, Metabolism, Retina & Pulmonary Hypertension, Janssen
Philippe Lopes-Fernandes, CBO, Ipsen
Amanda Wagner, CEO, Immunitas
Moderator: Chandra Ramanathan, Global Head, Innovation Hubs, Danaher
4:10 pm ET
VENTURE INVESTING: DEVELOPING THE SYNDICATE
Vineeta Agarwala, General Partner, a16z
Christine Brennan, Managing Director, Vertex Ventures HC
Ansbert Gadicke, Managing Director, MPM Capital
Nina Kjellson, General Partner, Canaan
Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund
4:40 pm ET
LONGWOOD FUND UPDATE
Lizzie Ngo, Principal, Longwood Fund
Thursday, September 22, 2022
7:00 am ET
LONGWOOD FUND INTRODUCTION
Christoph Westphal, General Partner, Longwood Fund
7:30 am ET
HARNESSING BIOMEDICAL INNOVATION
John Flavin, Chair, Pyxis Oncology
Trish Hurter, CEO, Lyndra
Joel Schneider, CEO, Carbon Biosciences
Krishnan Viswanadhan, President & COO, Be Bio
Moderator: Manuel Aivado, CEO, Aileron
8:00 am ET
PORTFOLIO COMPANY PRESENTATION
Amanda Wagner, CEO, Immunitas
Brian Fenton, CEO, Photys Therapeutics
8:20 am ET
GLOBAL MARKETS: WORKING ACROSS BORDERS
Al Beardsley, Chief Operating Officer, Galera Therapeutics
Keting Chu, CEO, Blue Jay Therapeutics
Rick Russell, CEO, Tract Pharmaceuticals
Cecilia Schott, WW Head, Precision Diagnostics, Novartis
Moderator: Zhen Su, CEO, Marengo Therapeutics
8:50 am ET
ACCELERATING DRUG DEVELOPMENT
Christian Antoni, Chief Development Officer, EQRx
Matt Gevaert, CEO, Kiyatec
Priya Singhal, Interim Head R&D, SVP, Global Head, Safety & Regulatory Sciences, Biogen
Pamela Stetkiewicz, COO, Arbor Biotechnologie
Moderator: James Sapirstein, CEO, First Wave BioPharmas
9:20 am ET
PREPARING FOR THE FUTURE OF R&D
Fabrice Chouraqui, CEO, Cellarity
Nenad Grmusa, SVP, Head R&D Strategy & External Innovation, CFO R&D, Takeda
Phil Larsen, Global Head, Research & Early Development, Bayer Pharmaceuticals
Raquel Mura, Head, R&D, North America, Sanofi
Al Sandrock, CEO, Voyager Therapeutics
Moderator: Luigi Gentile, CRO, BenchSci
9:50 am ET
BUILDING GLOBAL BIOPHARMAS
Janice Chen, CTO, Mammoth
Jonathan Gootenberg, Fellow, McGovern Institute
Ed Holson, Co-Founder & CSO, Photys Therapeutics
Amit Rakhit, CEO, Flare Therapeutics
Moderator: Bettina Cockroft, CMO, Sangamo
10:20 am ET
FIRESIDE CHAT
Ed Markey, Senator, Commonwealth of Massachusetts
Moderator: Christoph Westphal, General Partner, Longwood Fund
10:40 am ET
ADVANCING PLATFORM TECHNOLOGIES
Diana Brainard, CEO, AlloVir
Axel Hoos, CEO, Scorpion Therapeutics
Sheila Mikhail, CEO, AskBio
Mike Nally, CEO, Generate Biomedicines
Pascal Touchon, CEO, Atara
Moderator: Annalisa D’Andrea, President & CSO, ImmuneID
11:15 am ET
CLINICAL TRIAL EFFICIENCY
Al Gianchetti, CEO, XyloCor
Jamie Macdonald, CEO, Parexel
Gitte Pedersen, CEO, Genomic Expression
Oliver Rosen, President & CMO, Dynamicure
Moderator: Bill Hinshaw, CEO, Axcella
11:45 am ET
MAINTAINING MOMENTUM POST-IPO
Bill Hicks, Co-Chair, Securities & Capital Markets, Mintz
Aaron Schwartz, Head, BD, Ginkgo Bioworks
Mary Szela, CEO, TriSalus Life Sciences
Moderator: Mark McKenna, CEO, Prometheus
12:15 pm ET
INNOVATIVE PARTNERSHIPS
Ken Drazan, CEO, ArsenalBio
Sabrina Johnson, CEO, Daré Bioscience
Jason Kelly, CEO, Ginkgo Bioworks
Matthias Müllenbeck, SVP, Head, Global BD & Alliance Management, EMD Serono
Jennifer Petter, Chief Innovation Officer, Arrakis
Moderator: Brian McVeigh, CEO, Code Bio
12:50 pm ET
NOVEL THERAPEUTIC MODALITIES
Frederick Beddingfield, CEO, Kira Pharmaceuticals
Loise Francisco, SVP, Head, Biology, DEM Bio
Mark Exley, CSO, Imvax
Robert Mabry, CSO, Orna Therapeutics
Chad May, CSO, Serotiny
Moderator: Michal Preminger, Regional Head, Johnson & Johnson Innovation, East North America
1:25 pm ET
FIRESIDE CHAT
George Scangos, CEO, Vir
George Yancopoulos, President & CSO, Regeneron
Moderator: Colin Hill, CEO, GNS Healthcare
1:50 pm ET
RECRUITING TALENT, DEVELOPING CULTURE
Amira Barkal, CEO, Pheast Therapeutics
Christian Cortis, COO, Tectonic Therapeutics
Derrell Porter, CEO, Cellevolve Bio
Sam Waksal, CEO, Graviton Bioscience
Modertor: Sheila Gujrathi, Chair, ImmPACT Bio
2:20 pm ET
MOVING FROM DATA TO MEDICINE
Kara Carter, EIR, Evotec
Everett Crosland, CCO, Cognito Therapeutics
Najat Khan, Chief Data Science Officer, Global Head, Strategy & Operations, Janssen R&D
Neil Weir, CEO, Sitryx
Moderator: Piraye Beim, CEO, Celmatix
2:50 pm ET
FIRESIDE CHAT
Bob Langer, Scientific Founder, Moderna; Institute Professor, MIT
Aviv Regev, EVP, Research & Early Development, Genentech
Moderator: John Adkisson, CEO, Fish & Richardson
3:20 pm ET
PLACING PATIENTS AT THE CENTER
Karen Akinsanya, President, R&D, Therapeutics, Schrödinger
Sujuan Ba, CEO, National Foundation for Cancer Research
Greg Fiore, CEO, Exacis
Christopher Locher, CEO, Versatope
Gavin MacBeath, CSO, TScan Therapeutics
Moderator: Rob Lenz, SVP, Global Development, Amgen
3:50 pm ET
APPROACHES TO REGULATORY HURDLES
Jorge DiMartino, CMO, Kronos Bio
Ira Klein, Head, Medical Affairs & Payer Relations, Tempus Labs
Thomas Lonngren, former Executive Director, European Medicines Agency (EMA)
Kanya Rajangam, Chief Medical & Development Officer, Senti Biosciences
Raymond Sanchez, CMO, Cerevel Therapeutics
Moderator: Terry Mahn, Senior Principal, Fish & Richardson
4:20 pm ET
EVOLVING INVESTMENT TRENDS
Vik Bajaj, Managing Director, Foresite Capital
Arjun Goyal, Managing Director, Vida Ventures
Paulina Hill, Partner, Sanofi Ventures
Anat Naschitz, CEO, 9xchange
Dan Omstead, CEO, Tekla Capital
Moderator: Matthias Kleinz, SVP, Translational Science, UPMC Enterprises
4:50 pm ET
LONGWOOD FUND UPDATE
Lucy Liu, Principal, Longwood Fund
.png)
.jpg){kind=logo}
Speaking Faculty
